CN Patent
CN107488156B — 一种无定型葡萄糖醇的合成方法
Assigned to Shangshai Shyndec Pharmaceutical Co ltd · Expires 2020-05-26 · 6y expired
What this patent protects
本发明公开了一种一种无定型(1S)‑1,5‑脱水‑1‑[4‑氯‑3‑[(4‑乙氧基苯基)甲基]苯基]‑D‑葡萄糖醇的合成方法,其反应式如下: 本制备工艺反应条件温和,操作简便,适合于工业化生产;产物总收率较高,43~53%,易得到药用级的无定型6。
USPTO Abstract
本发明公开了一种一种无定型(1S)‑1,5‑脱水‑1‑[4‑氯‑3‑[(4‑乙氧基苯基)甲基]苯基]‑D‑葡萄糖醇的合成方法,其反应式如下: 本制备工艺反应条件温和,操作简便,适合于工业化生产;产物总收率较高,43~53%,易得到药用级的无定型6。
Drugs covered by this patent
- Farxiga (DAPAGLIFLOZIN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.